Evidence map›Paper›PMID 38457464›Full record

ArticlePLoS genetics2024

Long-read sequencing for fast and robust identification of correct genome-edited alleles: PCR-based and Cas9 capture methods.

Christopher V McCabe, Peter D Price, Gemma F Codner, Alasdair J Allan, Adam Caulder, Skevoulla Christou, Jorik Loeffler, Matthew Mackenzie, Elke Malzer, Joffrey Mianné and 10 more

Abstract read
In one paragraph

Article in PLoS genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Christopher V McCabeThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
Peter D PriceThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.ORCID 0000-0002-6118-1111
Gemma F CodnerThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.ORCID 0000-0002-6967-9803
Alasdair J AllanThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.ORCID 0000-0003-4784-6866
Adam CaulderThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
Skevoulla ChristouThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.ORCID 0000-0002-3906-2757
Jorik LoefflerThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.ORCID 0009-0009-9464-5849
Matthew MackenzieThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
Elke MalzerThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
Joffrey MiannéThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.ORCID 0000-0003-0893-9947
Krystian J NowickiThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.ORCID 0009-0001-9029-1125
Edward J O'NeillThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.ORCID 0000-0002-8884-0121
Fran J PikeThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
Marie HutchisonThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
Benoit Petit-DemoulièreUniversité de Strasbourg, CNRS, INSERM, Institut Clinique de la Souris (ICS), PHENOMIN, CELPHEDIA, Illkirch, France.ORCID 0000-0001-5616-7692
Michelle E StewartThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
Hilary GatesThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.
Sara WellsThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.ORCID 0000-0002-0572-0600
Nicholas D SandersonNuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Lydia TeboulThe Mary Lyon Centre, MRC Harwell, Oxfordshire, United Kingdom.ORCID 0000-0002-2789-8637

Funding

CRSPR II Supplement: Consortium for the production and cryopreservation of knockout miceU42OD011174 · OD · BAYLOR COLLEGE OF MEDICINE · PI BEAUDET, ARTHUR L. · 2012 to 2015
$17.7M
Medical Research Council MC_UP_2201/1Medical Research Council MC_UP_2201/2Medical Research Council MC_UP_2201/3NIH HHS U42 OD011174
6 · The paper itself

Abstract

backgroundRecent developments in CRISPR/Cas9 genome-editing tools have facilitated the introduction of precise alleles, including genetic intervals spanning several kilobases, directly into the embryo. However, the introduction of donor templates, via homology directed repair, can be erroneous or incomplete and these techniques often produce mosaic founder animals. Thus, newly generated alleles must be verified at the sequence level across the targeted locus. Screening for the presence of the desired mutant allele using traditional sequencing methods can be challenging due to the size of the interval to be sequenced, together with the mosaic nature of founders. METHODOLOGY/PRINCIPAL

findingsIn order to help disentangle the genetic complexity of these animals, we tested the application of Oxford Nanopore Technologies long-read sequencing at the targeted locus and found that the achievable depth of sequencing is sufficient to offset the sequencing error rate associated with the technology used to validate targeted regions of interest. We have assembled an analysis workflow that facilitates interrogating the entire length of a targeted segment in a single read, to confirm that the intended mutant sequence is present in both heterozygous animals and mosaic founders. We used this workflow to compare the output of PCR-based and Cas9 capture-based targeted sequencing for validation of edited alleles.

conclusionTargeted long-read sequencing supports in-depth characterisation of all experimental models that aim to produce knock-in or conditional alleles, including those that contain a mix of genome-edited alleles. PCR- or Cas9 capture-based modalities bring different advantages to the analysis.

Indexed as

CRISPR-Cas SystemsGene EditingAllelesAnimalsPolymerase Chain ReactionRecombinational DNA Repair

Identifiers

PMID38457464
PMCPMC10954187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.